PROM1 and cancer: The overexpression of CD133+ in LNCaP cells enhanced their cancer stem cell-like characteristics in terms of colony formation, migration, etc. The CD133+ group exhibited a bone metastasis rate of 80%, compared with 20% in the Vec group.